{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:40:03Z","timestamp":1780508403479,"version":"3.54.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clinthera.2025.05.006","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T22:08:45Z","timestamp":1749161325000},"page":"e19-e30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["New Approach Combination-Dosed Therapy for Nonalcoholic Steatohepatitis Versus Vitamin E: A Randomized Controlled Trial"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-0504","authenticated-orcid":false,"given":"Amr Y.","family":"Zakaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab","family":"Badawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnaa","family":"Osama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa M.","family":"El-Kalaawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2025.05.006_bib0001","doi-asserted-by":"crossref","DOI":"10.2196\/40653","article-title":"The global prevalence of nonalcoholic fatty liver disease and its association with cancers: systematic review and meta-analysis","volume":"12","author":"Muhamad","year":"2023","journal-title":"Interact J Med Res"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0002","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jhep.2022.10.022","article-title":"NASH cirrhosis trials and major adverse liver outcomes: big data needed","volume":"78","author":"Noureddin","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0004","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.3390\/cancers15225458","article-title":"From non-alcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): epidemiology, incidence, predictions, risk factors, and prevention","volume":"15","author":"Motta","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0006","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/hep.30094","article-title":"Healthcare cost and utilization in nonalcoholic fatty liver disease: real-world data from a large U.S. claims database","volume":"68","author":"Allen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5558731","article-title":"Activation of the peroxisome proliferator-activated receptors (PPAR-\u03b1\/\u03b3) and the fatty acid metabolizing enzyme protein CPT1A by camel milk treatment counteracts the high-fat diet-induced nonalcoholic fatty liver disease","volume":"2021","author":"AlNafea","year":"2021","journal-title":"PPAR Res"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0008","first-page":"792","article-title":"PPAR alpha as a metabolic modulator of the liver: role in the pathogenesis of nonalcoholic steatohepatitis (NASH)","volume":"11","author":"Todisco","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0009","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3390\/jcm13030901","article-title":"Malondialdehyde serum levels in a full characterized series of 430 rheumatoid arthritis patients","volume":"13","author":"Merino de Paz","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/livers2010003","article-title":"Oxidative stress in non-alcoholic fatty liver disease","volume":"2","author":"Smirne","year":"2022","journal-title":"Livers"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0011","article-title":"The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment","volume":"13","author":"Yu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0012","article-title":"Controversies and opportunities in the use of inflammatory markers for diagnosis or risk prediction in fatty liver disease","volume":"11","author":"Lambrecht","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0013","article-title":"The role of FGF21 and its analogs on liver associated diseases","volume":"9","author":"Falamarzi","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0014","article-title":"Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment","volume":"8","author":"Heyens","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0015","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jtcvs.2016.01.020","article-title":"Ventricular fibrogenesis activity assessed by serum levels of procollagen type III N-terminal amino peptide during the staged Fontan procedure","volume":"151","author":"Sugimoto","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0016","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH \u2013 current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0017","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/metabo13111115","article-title":"Advances in noninvasive biomarkers for nonalcoholic fatty liver disease","volume":"13","author":"G\u00eelc\u0103-Blanariu","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0018","first-page":"213","article-title":"Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis","volume":"35","author":"Sinakos","year":"2022","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0019","article-title":"Current, emerging, and potential therapies for non-alcoholic steatohepatitis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0020","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants","volume":"98","author":"Jomova","year":"2024","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0021","doi-asserted-by":"crossref","first-page":"60","DOI":"10.21037\/tgh-20-247","article-title":"Narrative review of current and emerging pharmacological therapies for nonalcoholic steatohepatitis","volume":"6","author":"Satiya","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0022","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/antiox10060967","article-title":"N-Acetylcysteine (NAC): impacts on human health","volume":"10","author":"Ten\u00f3rio","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312635","article-title":"N-Acetylcysteine can induce massive oxidative stress, resulting in cell death with apoptotic features in human leukemia cells","volume":"22","author":"Mlejnek","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/1463-1741.149565","article-title":"Is rosuvastatin protective against on noise-induced oxidative stress in rat serum?","volume":"17","author":"Koc","year":"2015","journal-title":"Noise Health"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0025","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/jcm11051313","article-title":"Antioxidant effects of statins by modulating Nrf2 and Nrf2\/HO-1 signaling in different diseases","volume":"11","author":"Mansouri","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0026","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/metabo12040298","article-title":"Nonalcoholic fatty liver disease and endocrine axes\u2013a scoping review","volume":"12","author":"Von-Hafe","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0027","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/apt.16583","article-title":"Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH","volume":"54","author":"Majzoub","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0028","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J Physiol Biochem"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2025.05.006_bib0029","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.4103\/sja.SJA_559_18","article-title":"The CONSORT statement","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0030","first-page":"357","article-title":"Screening for nonalcoholic fatty liver disease in the primary care clinic","volume":"15","author":"Pandyarajan","year":"2019","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0031","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3945\/ajcn.2008.26698","article-title":"Estimates of excess deaths associated with body mass index and other anthropometric variables","volume":"89","author":"Flegal","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0032","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1047-2797(03)00067-X","article-title":"Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. Waist to stature ratio is more strongly associated with cardiovascular risk factors than other simple anthropometric indices","volume":"13","author":"Ho","year":"2003","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0033","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/archdischild-2015-309645","article-title":"Anthropometric measures are simple and accurate paediatric weight-prediction proxies in resource-poor settings with a high HIV prevalence","volume":"102","author":"Whitfield","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0034","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/jamainternmed.2015.2405","article-title":"Prevalence of overweight and obesity in the United States, 2007-2012","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/jcm11051201","article-title":"The utility and diagnostic accuracy of transient elastography in adults with morbid obesity: a prospective study","volume":"11","author":"Ali","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0036","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jceh.2021.06.008","article-title":"FibroScan-AST (FAST) score for nonalcoholic steatohepatitis \u2013 validation in an Indian cohort","volume":"12","author":"De","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0037","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.3390\/jcm11154394","article-title":"Non-invasive detection of fibrotic NASH in NAFLD patients with low or intermediate FIB-4","volume":"11","author":"John","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0038","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.cgh.2022.03.044","article-title":"Development and validation of a score for fibrotic nonalcoholic steatohepatitis","volume":"21","author":"Tavaglione","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0039","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/apt.14621","article-title":"Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH","volume":"47","author":"Boursier","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.17352\/2455-5282.000155","article-title":"Evaluation of the effect of total saponins and tannins isolated from Dialium guineense stem bark on CCl4-induced hepatotoxicity in Wistar rats","volume":"9","author":"Abu","year":"2022","journal-title":"Glob J Med Clin Case Rep"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0041","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000459586","article-title":"Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine","volume":"12","author":"Belfield","year":"1971","journal-title":"Enzyme"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0042","article-title":"Evaluation of homocysteine and gamma-glutamyl transferase concentrations as markers of chronic kidney disease: an Indian perspective","volume":"14","author":"R","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0043","first-page":"115","article-title":"Metformin ameliorates oxidative stress induced by diabetes mellitus and hepatocellular carcinoma in rats","volume":"9","author":"Ahmed Mobasher","year":"2020","journal-title":"Rep Biochem Mol Biol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0044","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/clinchem\/26.5.555","article-title":"Kinetic serum creatinine assays. II. A critical evaluation and review","volume":"26","author":"Bowers","year":"1980","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF01484513","article-title":"Enzymatic urea determination in the blood and serum in the Warburg optical test","volume":"43","author":"Talke","year":"1965","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0046","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/clinchem\/18.8.829","article-title":"Enzymatic kinetic rate and end-point analyses of substrate, by use of a GeMSAEC fast analyzer","volume":"18","author":"Tiffany","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0047","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/clinchem\/26.2.227","article-title":"Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid\/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine","volume":"26","author":"Fossati","year":"1980","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0048","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0049","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM197902223000808","article-title":"Receptors, antireceptor antibodies and mechanisms of insulin resistance","volume":"300","author":"Flier","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0004-28032010000200009","article-title":"Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals","volume":"47","author":"Salgado","year":"2010","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0051","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ab.2016.10.021","article-title":"Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges","volume":"524","author":"Tsikas","year":"2017","journal-title":"Anal Biochem"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0052","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00210-020-01881-7","article-title":"Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-\u03b21 and iNOS","volume":"393","author":"Gungor","year":"2020","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0053","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43094-024-00593-6","article-title":"The possible anti-inflammatory effect of extra virgin olive oil with colchicine in treatment of resistant cases of familial Mediterranean fever in a cohort of pediatric Egyptian patients","volume":"10","author":"Osman","year":"2024","journal-title":"Futur J Pharm Sci"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0054","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/antiox9080759","article-title":"Oxidative stress and pro-inflammatory status in patients with non-alcoholic fatty liver disease","volume":"9","author":"Monserrat-Mesquida","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0055","first-page":"2546","article-title":"Correlation of CD3+\/CD4+, and serum CK-18 fragment levels with glucose and lipid metabolism in elderly type 2 diabetes patients with nonalcoholic fatty liver disease","volume":"13","author":"Zhao","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0056","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ejcdt.2014.06.014","article-title":"Study of the level of sputum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor metalloproteinase-1 (TIMP-1) in COPD patients","volume":"63","author":"Esa","year":"2014","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0057","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12916-016-0638-y","article-title":"No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial","volume":"14","author":"Barchetta","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0058","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41687-018-0052-7","article-title":"Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review","volume":"2","author":"Kennedy-Martin","year":"2018","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0059","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/pubmed\/21.3.255","article-title":"Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, the Health Survey for England and the Oxford Healthy Life Survey","volume":"21","author":"Bowling","year":"1999","journal-title":"J Public Health Med"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0060","series-title":"Fundamentals of Hand Therapy","first-page":"98","article-title":"Chapter 6 \u2013 Assessment of functional outcomes","author":"Von Der Heyde","year":"2007"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0061","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.cgh.2021.07.020","article-title":"Obeticholic acid impact on quality of life in patients with nonalcoholic steatohepatitis: REGENERATE 18-month interim analysis","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0062","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(04)00457-4","article-title":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.973366","article-title":"Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease","volume":"13","author":"Fu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0064","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1136\/gutjnl-2019-319104","article-title":"Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges","volume":"69","author":"Dufour","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0065","article-title":"Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease","volume":"111S","author":"Long","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0066","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1478-3231.2011.02451.x","article-title":"Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease","volume":"31","author":"Miller","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0067","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1365-2036.2010.04480.x","article-title":"A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients","volume":"32","author":"Anty","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0068","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jhep.2011.12.025","article-title":"Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers","volume":"56","author":"Shen","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0069","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93435-x","article-title":"The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases","volume":"11","author":"Fujii","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0071","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0072","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0073","first-page":"81","article-title":"The risk factors of fibrosis in nonalcoholic steatohepatitis","volume":"40","author":"Fierbin\u0163eanu-Braticevici","year":"2002","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0074","first-page":"119","article-title":"A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis","volume":"16","author":"Ba\u015fkol","year":"2005","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.26030","article-title":"Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease","volume":"57","author":"Tanwar","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0076","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.3390\/nu15173733","article-title":"The effect of vitamin E supplementation on serum aminotransferases in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis","volume":"15","author":"Vogli","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0077","doi-asserted-by":"crossref","first-page":"135","DOI":"10.31351\/vol31iss2pp135-143","article-title":"Therapeutic effects of vitamin E in non-alcoholic fatty liver disease: an open-labeled clinical trial","volume":"31","author":"Jawad Fairooz","year":"2022","journal-title":"Iraqi J Pharm Sci"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0078","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/s0004-2803.201900000-36","article-title":"N-Acetylcysteine and\/or ursodeoxycholic acid associated with metformin in non-alcoholic steatohepatitis: an open-label multicenter randomized controlled trial","volume":"56","author":"Oliveira","year":"2019","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0079","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/antiox9121283","article-title":"N-Acetyl cysteine targets hepatic lipid accumulation to curb oxidative stress and inflammation in NAFLD: a comprehensive analysis of the literature","volume":"9","author":"Dludla","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0080","first-page":"12","article-title":"N-Acetylcysteine improves liver function in patients with non-alcoholic fatty liver disease","volume":"10","author":"Khoshbaten","year":"2010","journal-title":"Hepat Mon"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0081","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/hepr.12821","article-title":"Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice","volume":"47","author":"Marinho","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0082","first-page":"57","article-title":"Protective effect of N-acetyl-L-cysteine and rosuvastatin against oxidative stress in fibroblasts from asymptomatic patients with X-ALD: a preliminary study","volume":"41","author":"Marchetti","year":"2021","journal-title":"Clin Biomed Res"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0083","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijcard.2016.03.009","article-title":"Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"212","author":"Park","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0084","first-page":"249","article-title":"Protective effects of N-acetylcysteine against the statins cytotoxicity in freshly isolated rat hepatocytes","volume":"4","author":"Abdoli","year":"2014","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0085","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0086","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4254\/wjh.v7.i27.2749","article-title":"Vitamin E reduces liver stiffness in nonalcoholic fatty liver disease","volume":"7","author":"Fukui","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0087","first-page":"553","article-title":"S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis","volume":"7","author":"Mazo","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0088","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.3748\/wjg.v21.i25.7860","article-title":"Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome","volume":"21","author":"Kargiotis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0089","doi-asserted-by":"crossref","DOI":"10.1038\/srep40461","article-title":"A nitric oxide-donating statin decreases portal pressure with a better toxicity profile than conventional statins in cirrhotic rats","volume":"7","author":"Rodr\u00edguez","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11894-017-0584-7","article-title":"Use of statins in patients with chronic liver disease and cirrhosis: current views and prospects","volume":"19","author":"Vargas","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0091","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tvjl.2004.02.001","article-title":"Oxidative status during late pregnancy and early lactation in dairy cows","volume":"169","author":"Castillo","year":"2005","journal-title":"Vet J"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0092","first-page":"1079","article-title":"The protective role of vitamin E against oxidative stress and immunosuppression induced by non-esterified fatty acids in bovine peripheral blood leukocytes","volume":"14","author":"Li","year":"2024","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0093","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","article-title":"The chemistry and biological activities of N-acetylcysteine","volume":"1830","author":"Samuni","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0094","first-page":"11","article-title":"A review on various uses of N-acetyl cysteine","volume":"19","author":"Mokhtari","year":"2017","journal-title":"Cell J"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jjcc.2015.05.017","article-title":"High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: the Standard versus high-dose therApy with rosuvastatin for lipiD lowering (SARD) trial","volume":"67","author":"Nishikido","year":"2016","journal-title":"J Cardiol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0096","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6229460","article-title":"The role of mesenchymal stem cells with ascorbic acid and N-acetylcysteine on TNF-\u03b1, IL 1\u03b2, and NF-\u03ba\u03b2 expressions in acute pancreatitis in albino rats","volume":"2021","author":"Abdelhafez","year":"2021","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0097","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ymgme.2021.01.005","article-title":"TRMU deficiency: a broad clinical spectrum responsive to cysteine supplementation","volume":"132","author":"Murali","year":"2021","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0098","doi-asserted-by":"crossref","DOI":"10.1177\/15593258231179900","article-title":"Beneficial effect of rosuvastatin therapy on spleen injury induced by gamma irradiation in rats: targeting Nrf2\/EPRE pathway","volume":"21","author":"Fahim","year":"2023","journal-title":"Dose Response"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0099","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/ph14040341","article-title":"A novel combination therapy using rosuvastatin and lactobacillus combats dextran sodium sulfate-induced colitis in high-fat diet-fed rats by targeting the TXNIP\/NLRP3 interaction and influencing gut microbiome composition","volume":"14","author":"Saber","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0100","first-page":"795","article-title":"Rosuvastatin suppresses TNF-\u03b1-induced matrix catabolism, pyroptosis and senescence via the HMGB1\/NF-\u03baB signaling pathway in nucleus pulposus cells","volume":"55","author":"Chen","year":"2023","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.113914","article-title":"Combined intervention with N-acetylcysteine and desipramine alleviated silicosis development by regulating the Nrf2\/HO-1 and ASMase\/ceramide signaling pathways","volume":"242","author":"Tang","year":"2022","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2008.02.012","article-title":"Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis","volume":"49","author":"Yang","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0103","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/HJH.0b013e32834abceb","article-title":"Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation","volume":"29","author":"Solini","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0104","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000360860","article-title":"Rosuvastatin inhibits TIMP-2 and promotes myocardial angiogenesis","volume":"93","author":"Siddiqui","year":"2014","journal-title":"Pharmacology"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0105","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijcard.2009.12.028","article-title":"Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study","volume":"146","author":"Ashton","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0106","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s12350-019-01857-y","article-title":"Assessment of therapeutic effects of statin on cardiac sympathetic nerve activity after reperfusion therapy in patients with first ST-segment elevation myocardial infarction and normal low-density lipoprotein cholesterol","volume":"28","author":"Takahashi","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0107","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3320325","article-title":"Drug-induced liver injury: clinical evidence of N-acetyl cysteine protective effects","volume":"2021","author":"Ntamo","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0108","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00432-011-1041-x","article-title":"Redox regulation of cytokeratin 18 protein by NADPH oxidase 1 in preneoplastic human epithelial cells","volume":"137","author":"Sattayakhom","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0109","doi-asserted-by":"crossref","first-page":"76","DOI":"10.26724\/2079-8334-2022-3-81-76-82","article-title":"Quercetin effectiveness in the complex hypolipidemic therapy of patients with nonalcoholic fatty liver disease with metabolic syndrome","volume":"3","author":"Kravchenko","year":"2022","journal-title":"World Med Biol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0110","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacl.2016.02.021","article-title":"The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial","volume":"10","author":"Khatami","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0111","first-page":"2472","article-title":"N-Acetylcysteine for chronic kidney disease: a systematic review and meta-analysis","volume":"13","author":"Ye","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0112","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/14740338.6.5.573","article-title":"The safety of rosuvastatin: effects on renal and hepatic function","volume":"6","author":"Guthrie","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0113","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1237869","article-title":"Effects of N-acetylcysteine on aging cell and obesity complications in obese adults: a randomized, double-blind clinical trial","volume":"10","author":"Sohouli","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0114","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1209614","article-title":"The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"10","author":"Liu","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.clinthera.2025.05.006_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9949453","article-title":"N-Acetylcysteine: a review of clinical usefulness (an old drug with new tricks)","volume":"2021","author":"Schwalfenberg","year":"2021","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.clinthera.2025.05.006_bib116","doi-asserted-by":"crossref","first-page":"105299","DOI":"10.1016\/j.jff.2022.105299","article-title":"The effects of N-acetylcysteine administration on metabolic status and serum adiponectin levels in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled trial","volume":"99","author":"Panahi","year":"2022","journal-title":"J Funct Foods"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825001705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825001705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:09:14Z","timestamp":1753880954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825001705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":116,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0149291825001705"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.05.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Approach Combination-Dosed Therapy for Nonalcoholic Steatohepatitis Versus Vitamin E: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}